First Allied Advisory Services Inc. trimmed its holdings in Becton, Dickinson and Company (NYSE:BDX) by 5.5% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 2,671 shares of the medical instruments supplier’s stock after selling 156 shares during the quarter. First Allied Advisory Services Inc.’s holdings in Becton, Dickinson and were worth $524,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Almanack Investment Partners LLC. bought a new stake in shares of Becton, Dickinson and in the 1st quarter worth approximately $105,000. Mitsubishi UFJ Securities Holdings Co. Ltd. lifted its holdings in shares of Becton, Dickinson and by 55.8% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 670 shares of the medical instruments supplier’s stock worth $131,000 after acquiring an additional 240 shares during the last quarter. Parkside Financial Bank & Trust lifted its holdings in shares of Becton, Dickinson and by 8.1% in the 2nd quarter. Parkside Financial Bank & Trust now owns 684 shares of the medical instruments supplier’s stock worth $133,000 after acquiring an additional 51 shares during the last quarter. Harfst & Associates Inc. lifted its holdings in shares of Becton, Dickinson and by 46.4% in the 2nd quarter. Harfst & Associates Inc. now owns 697 shares of the medical instruments supplier’s stock worth $135,000 after acquiring an additional 221 shares during the last quarter. Finally, Financial Architects Inc lifted its holdings in shares of Becton, Dickinson and by 8.0% in the 2nd quarter. Financial Architects Inc now owns 731 shares of the medical instruments supplier’s stock worth $142,000 after acquiring an additional 54 shares during the last quarter. Hedge funds and other institutional investors own 87.12% of the company’s stock.

In other Becton, Dickinson and news, insider Gary M. Cohen sold 15,512 shares of the stock in a transaction on Monday, September 11th. The stock was sold at an average price of $203.77, for a total value of $3,160,880.24. Following the sale, the insider now owns 95,781 shares in the company, valued at $19,517,294.37. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Ellen R. Strahlman sold 9,283 shares of the stock in a transaction on Thursday, August 10th. The stock was sold at an average price of $198.21, for a total value of $1,839,983.43. Following the completion of the sale, the insider now owns 26,638 shares in the company, valued at approximately $5,279,917.98. The disclosure for this sale can be found here. In the last quarter, insiders sold 75,904 shares of company stock worth $15,242,688. Insiders own 1.40% of the company’s stock.

Becton, Dickinson and Company (NYSE BDX) opened at 211.83 on Friday. The stock has a market capitalization of $48.20 billion, a P/E ratio of 61.35 and a beta of 1.05. Becton, Dickinson and Company has a 12 month low of $161.29 and a 12 month high of $212.54. The firm’s 50-day moving average is $198.29 and its 200-day moving average is $193.82.

Becton, Dickinson and (NYSE:BDX) last released its earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 earnings per share for the quarter, topping analysts’ consensus estimates of $2.44 by $0.02. Becton, Dickinson and had a return on equity of 22.53% and a net margin of 6.25%. The business had revenue of $3.04 billion for the quarter, compared to analyst estimates of $3.06 billion. During the same quarter last year, the firm posted $2.35 earnings per share. The business’s revenue was down 5.1% compared to the same quarter last year. On average, equities analysts expect that Becton, Dickinson and Company will post $9.46 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, September 29th. Shareholders of record on Friday, September 8th were paid a $0.73 dividend. The ex-dividend date was Thursday, September 7th. This represents a $2.92 dividend on an annualized basis and a yield of 1.38%. Becton, Dickinson and’s payout ratio is 83.43%.

BDX has been the topic of several analyst reports. Zacks Investment Research raised shares of Becton, Dickinson and from a “sell” rating to a “hold” rating in a research note on Friday. Wells Fargo & Company initiated coverage on shares of Becton, Dickinson and in a research note on Friday, September 22nd. They issued an “outperform” rating and a $225.00 target price on the stock. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $213.00 target price on shares of Becton, Dickinson and in a research note on Tuesday, September 12th. BidaskClub raised shares of Becton, Dickinson and from a “hold” rating to a “buy” rating in a research note on Monday, August 14th. Finally, Cowen and Company reaffirmed a “buy” rating and issued a $230.00 target price on shares of Becton, Dickinson and in a research note on Monday, August 14th. Five equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $202.07.

ILLEGAL ACTIVITY WARNING: This piece was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2017/10/22/first-allied-advisory-services-inc-sells-156-shares-of-becton-dickinson-and-company-bdx.html.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Stock Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related stocks with our FREE daily email newsletter.